Compare os principais médicos e preços de Xofigo Rádio-223 em Turquia. Encontre o seu melhor par aqui.

Escolha o país com os melhores preços para serviços médicos

Compare os preços de Xofigo Rádio-223 entre os principais países

Toque em um país para ver os principais médicos e preços

South Korea

Ukraine

Mexico

Turkey

Thailand

Israel

$4,100 - $6,500

$4,500 - $7,000

$6,000 - $9,000

$7,000 - $10,000

$7,500 - $9,500

$7,800 - $10,500

$2,000

$4,000

$6,000

$8,000

$10,000

Receba planos de tratamento personalizados gratuitos e escolha a melhor opção. Sem compromisso · Sem pagamentos pelos nossos serviços

Hasan Biri

39 anos de experiência
Localização: Turquia, Ancara
Clínica:
2.0
Private Koru Ankara Hospital
O Prof. Dr. Hasan Biri é especialista em uro-oncologia, com extensa pesquisa e prática clínica no Kneed Norris Center da USC. Sua perícia concentra-se nos cancros da próstata, bexiga e rim.
- Treinado em técnicas de prostatectomia radical e cistectomia
- Mais de 80 publicações nacionais e internacionais em uro-oncologia
- Presidente fundador do Koru Healthcare Group
- Especialista em cirurgia robótica para cancros urológicos
Leia mais

Consulta médica

Preço sob consulta

Bookimed Insights: Principais especialistas em Xofigo Rádio-223 em Turquia (2026)

A Bookimed coordenou 1 solicitações para Xofigo Rádio-223 em Turquia, trabalhando em conjunto com 1 especialistas bem avaliados. Os médicos nesta tabela são selecionados com base em credenciais internacionais, expertise clínica e resultados dos pacientes. O ranking de 2026 é formado com dados verificados de casos reais e programas atuais das nossas clínicas parceiras.

Classificação	Médico	experiência	Bom para	O que os diferencia	Clínica e localização	Consulta
#1	Hasan Biri	39 anos de experiência	Cirurgias uro-oncológicas robóticas	Pioneiro em cirurgias uro-oncológicas robóticas com pesquisa na USC. Publicou extensivamente sobre tratamentos de cancro da próstata.	Private Koru Ankara Hospital Turquia	Preço sob consulta

FAQ

Estas Perguntas Frequentes provêm de pacientes reais que procuram assistência médica através da Bookimed. As respostas são dadas por coordenadores médicos experientes e representantes de confiança das clínicas.

What qualifications do leading Xofigo (Radium-223) doctors in Turkey hold?

Leading Xofigo (Radium-223) doctors in Turkey hold specialized Medical Oncology or Nuclear Medicine certifications. Many are professors with international training at institutions like MD Anderson Cancer Center. They maintain board certifications and European fellowships to treat advanced prostate cancer with bone metastases safely.

International training: Top specialists completed fellowships at MD Anderson or Heidelberg University.
Board certifications: Leading physicians hold ESMO or European Board of Urology (FEBU) credentials.
Sub-specialized residency: Doctors undergo 4+ years of specialized training in oncology or nuclear medicine.
Academic expertise: Many specialists are professors with over 40 peer-reviewed international publications.

Bookimed Expert Insight: Data shows that premier Turkish oncologists, such as Dr. Mustafa Solak at Hisar Hospital, often possess fellowship training from the U.S.-based MD Anderson Cancer Center. This specific background is a strong indicator of proficiency in radionuclide therapies like Xofigo. Patients benefit from this high level of academic rigor and access to multidisciplinary tumor boards in JCI-accredited facilities.

Patient Consensus: Patients emphasize the importance of choosing a doctor with specific experience in treating bone-metastatic prostate cancer. They note that the coordination of blood count monitoring and pain control is vital for a smooth recovery. Many travelers feel more confident when treated at large academic centers or hospitals with international accreditations.

Who are the top-rated doctors performing Xofigo treatments in Turkey?

Top-rated Turkish specialists for Xofigo Radium-223 treatments include board-certified oncologists and urologists training at leading global institutions. These doctors specialize in treating advanced prostate cancer with bone metastases. Many hold ESMO certification and fellowships from prestigious centers like MD Anderson Cancer Center.

Expert training: Dr. Mustafa Solak completed a fellowship at the University of Texas MD Anderson.
Academic leadership: Dr. Nail Paksoy serves as Associate Professor with ESMO Board Certification.
Surgical integration: Dr. Hasan Biri focuses on robotic surgery and advanced system radionuclide treatments.
Extensive research: Dr. Cevper Ersoz authored over 130 publications on urological cancer therapies.

Bookimed Expert Insight: Data shows that leading Turkish specialists for Xofigo often integrate radionuclide therapy with international research backgrounds. For example, Dr. Mustafa Solak at Hisar Hospital Intercontinental offers consultations for $100. This provides patients with access to US-style treatment protocols from a fellowship-trained expert at a local cost.

Patient Consensus: Patients note that coordination between nuclear medicine and oncology departments is very smooth. They appreciate how doctors explain the targeted nature of the alpha-emitter therapy for bone health. Many mention feeling safer knowing their specialist has international experience in complex prostate cases.

How do Turkish doctors determine if a patient is eligible for Radium-223?

Turkish oncologists determine eligibility for Radium-223 by verifying metastatic castration-resistant prostate cancer that primarily affects the bones. Doctors like Dr. Mustafa Solak at Hisar Hospital Intercontinental ensure disease hasn't spread to internal organs. They confirm previous hormonal therapies failed before starting this targeted alpha-particle treatment.

Bone metastasis check: Specialists require bone scans showing multiple lesions without visceral involvement.
Blood marrow function: Patients must have hemoglobin levels of at least 10 g/dL.
Treatment history: Eligibility requires progression after at least two lines of systemic therapy.
Symptom review: Doctors confirm the presence of symptomatic bone pain requiring regular analgesics.

Bookimed Expert Insight: Turkish specialists often serve as principal investigators in global clinical trials for Xofigo. Dr. Nail Paksoy at Medipol University Hospital has participated in over 8 international trials. This deep research involvement means Turkish doctors often have earlier, more hands-on experience with Radium-223 protocols than general oncologists.

Patient Consensus: Patients find that blood tests are the most frequent gatekeeper during the screening process. They note that doctors are very conservative about bone marrow health before clearing the first injection. Many were surprised that having bone-only disease was actually a requirement for qualifying.

What diagnostic routine do doctors in Turkey use before administering Xofigo?

Turkish oncologists follow global protocols requiring bone scans and detailed blood panels before every Xofigo injection. These diagnostics verify symptomatic bone metastasis presence while ensuring bone marrow health remains stable throughout the therapy. Most clinics require updated imaging to confirm no significant visceral spread exists before starting.

Blood count monitoring: Specialists check neutrophils and platelets to ensure marrow can handle radiation.
Imaging verification: Doctors use bone scans or PET-CT to confirm the disease remains bone-predominant.
Organ function screening: Routine labs assess kidney and liver health before each of the six sessions.
Oncology consultation: Specialists like Dr. Mustafa Solak review previous treatments, including prior chemotherapy history.

Bookimed Expert Insight: Turkish specialists often hold dual international expertise that influences their diagnostic precision. For instance, Dr. Nail Paksoy is ESMO board-certified and has led international Bayer clinical trials for Xofigo. This research background means patients receive a diagnostic routine identical to leading Western trials, often at JCI-accredited facilities like Hisar Hospital Intercontinental.

Patient Consensus: Patients note that recent scans are vital to prove the cancer is mostly in the bones. They say frequent blood tests are regular but necessary to keep the treatment moving forward safely. Those who have been through it emphasize that doctors will pause the schedule if blood counts drop too low.

Melhores Xofigo Rádio-223 médicos em Ancara - TOP-1 médicos

Receba orçamentos de 3 principais especialistas em Xofigo Rádio-223 em Turquia